Pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) ended 2023 with net profit of RON80.7 million, up 109.5% from 2022, and a turnover of RON600.8 million, up 7.2% on the year, in line with calculations by Ziarul Financiar (ZF) daily based on data from the company's annual preliminary financial report published at the Bucharest Stock Exchange.